Cargando…
Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure
Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatme...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099355/ https://www.ncbi.nlm.nih.gov/pubmed/35572467 http://dx.doi.org/10.3389/ti.2022.10108 |
_version_ | 1784706586667646976 |
---|---|
author | Schulz, Martin S. Gu, Wenyi Schnitzbauer, Andreas A. Trebicka, Jonel |
author_facet | Schulz, Martin S. Gu, Wenyi Schnitzbauer, Andreas A. Trebicka, Jonel |
author_sort | Schulz, Martin S. |
collection | PubMed |
description | Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatment for patients with decompensated liver cirrhosis and, due to the high mortality rates, particularly for ACLF patients. In the last decade, a plethora of studies has produced compelling evidence in favor of LT in ACLF, demonstrating high post-LT survival rates and excessive waitlist mortality. The importance of LT in these patients is underscored by the fact that no specific therapy for ACLF is available yet, rendering expeditious life-saving LT to be the only feasible treatment option for some ACLF patients. This review aims to provide an overview on pathophysiology, clinical trajectory, and clinical management of ACLF and to delineate the current literature regarding perspectives and limitations of LT as a life-saving treatment option for ACLF patients. |
format | Online Article Text |
id | pubmed-9099355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90993552022-05-14 Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure Schulz, Martin S. Gu, Wenyi Schnitzbauer, Andreas A. Trebicka, Jonel Transpl Int Health Archive Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatment for patients with decompensated liver cirrhosis and, due to the high mortality rates, particularly for ACLF patients. In the last decade, a plethora of studies has produced compelling evidence in favor of LT in ACLF, demonstrating high post-LT survival rates and excessive waitlist mortality. The importance of LT in these patients is underscored by the fact that no specific therapy for ACLF is available yet, rendering expeditious life-saving LT to be the only feasible treatment option for some ACLF patients. This review aims to provide an overview on pathophysiology, clinical trajectory, and clinical management of ACLF and to delineate the current literature regarding perspectives and limitations of LT as a life-saving treatment option for ACLF patients. Frontiers Media S.A. 2022-03-17 /pmc/articles/PMC9099355/ /pubmed/35572467 http://dx.doi.org/10.3389/ti.2022.10108 Text en Copyright © 2022 Schulz, Gu, Schnitzbauer and Trebicka. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Health Archive Schulz, Martin S. Gu, Wenyi Schnitzbauer, Andreas A. Trebicka, Jonel Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure |
title | Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure |
title_full | Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure |
title_fullStr | Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure |
title_full_unstemmed | Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure |
title_short | Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure |
title_sort | liver transplantation as a cornerstone treatment for acute-on-chronic liver failure |
topic | Health Archive |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099355/ https://www.ncbi.nlm.nih.gov/pubmed/35572467 http://dx.doi.org/10.3389/ti.2022.10108 |
work_keys_str_mv | AT schulzmartins livertransplantationasacornerstonetreatmentforacuteonchronicliverfailure AT guwenyi livertransplantationasacornerstonetreatmentforacuteonchronicliverfailure AT schnitzbauerandreasa livertransplantationasacornerstonetreatmentforacuteonchronicliverfailure AT trebickajonel livertransplantationasacornerstonetreatmentforacuteonchronicliverfailure |